-
1 Comment
Blueberries Medical Corp is currently in a long term downtrend where the price is trading 3.5% below its 200 day moving average.
From a valuation standpoint, the stock is 60.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 515.4.
Blueberries Medical Corp's total revenue rose by inf% to $35K since the same quarter in the previous year.
Its net income has increased by 52.2% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.0% to $-1M since the same quarter in the previous year.
Based on the above factors, Blueberries Medical Corp gets an overall score of 4/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | CA09609Y1016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 3M |
---|---|
PE Ratio | None |
Target Price | None |
Beta | 2.32 |
Dividend Yield | None |
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1OA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025